ACQUIRED · 2025
Who Acquired Horizon Infusions?
Rubicon · $130.0M · 2025
The acquisition
Horizon Infusions was acquired by Rubicon in 2025 for $130.0M.
Horizon Infusions at time of acquisition
EBITDA
$8.0M
Deal value
$130.0M
Own a pharmacy business? See what it's worth.
Rubicon acquired Horizon Infusions for $130.0M. Get an M&A-grade EBITDA range and sellability score for your own business, benchmarked against 25,592 real transactions. 2 minutes, no signup.
- ✓Sellability score with 5-driver breakdown and lift estimates
- ✓Named comparable M&A transactions in your sub-vertical
- ✓AI-written analysis grounded in your specific inputs
Similar pharmacy acquisitions
- University Compounding Pharmacy · acquired by Fagron in 2026 · $41.5M
- Choice Specialty Pharmacy Group · acquired by Better Choice Company, Inc. in 2025 · $28.0M
- KabaFusion · acquired by Nautic Partners in 2025 · $2.20B
- Soleo Health · acquired by Court Square Capital and WindRose Health in 2025 · $1.10B
- West Olympia Pharmacy Inc. · acquired by Medicure Inc. in 2025 · $1.0M
More on pharmacy valuations
- Value a medical practice
- Value a dental practice
- Value a veterinary practice
- Value a pharmacy· run the calculator
- Pharmacy median multiples· real-deal benchmarks
- Who buys pharmacy businesses?· active buyers
- Who acquired University Compounding Pharmacy?· buyer profile
- How to value a pharmacy· long-form guide
Sourced from Press reporting. Full deal page
Citation: ExitValue.ai. (2025). Horizon Infusions acquired by Rubicon. https://exitvalue.ai/acquired/horizon-infusions